PIN TRL LNR NEUT +4 40ID 56OD
Report
- Report Number
- 1818910-2015-29032
- Event Type
- Malfunction
- Date Received
- August 26, 2015
- Date of Event
- July 28, 2015
- Report Date
- July 28, 2015
- Manufacturer
- DEPUY ORTHOPAEDICS, INC.
- Product Code
- LHX
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. (B)(4).
THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. REVIEW OF THE DEVICE HISTORY RECORDS AND/OR A LOT SPECIFIC COMPLAINT DATABASE SEARCH WAS NOT POSSIBLE AS THE LOT CODE REQUIRED WAS NOT PROVIDED. PREVIOUS INVESTIGATIONS FOUND THE USER OVER-TIGHTENING THE THREADED INSERT DURING USE AND INTENTIONALLY DISASSEMBLING THE SNAP RING FROM THE SCREW FOR SURGICAL PREFERENCE OR CLEANING ARE SUSPECTED ROOT CAUSES. (B)(4) WAS CONDUCTED IN NOVEMBER OF 2011. THE INVESTIGATION DID NOT ESTABLISH THE NEED FOR CORRECTIVE ACTION BASED ON NO IMMEDIATE PATIENT RISK, THE LOW FREQUENCY OF REPORTED EVENTS, AND SUSPECTED CUSTOMER MISUSE AS THE ROOT CAUSE. NO EVIDENCE WAS FOUND OF PRODUCT OR DESIGN ERROR AS A CONTRIBUTING FACTOR. ALL SUBSEQUENT COMPLAINTS REGARDING FAILURES WITHIN THE PINNACLE TRIAL LINER PRODUCT FAMILY WILL BE MONITORED UNDER POST MARKET SURVEILLANCE SEP 419. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.
WHILE TRIALING THE LINER, THE MIDDLE SCREW SNAPPED OFF WHERE THE SCREW IS HELD ON BY THE PIN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 564560 | PIN TRL LNR NEUT +4 40ID 56OD | HIP INSTRUMENT/TRIAL | LHX | DEPUY ORTHOPAEDICS, INC. | UNKNOWN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR |